Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

iCVD Polymer Thin Film Bio‐Interface‐Performance for Fibroblasts, Cancer‐Cells, and Viruses Connected to Their Functional Groups and In Silico Studies (Adv. Mater. Interfaces 1/2024)

Polymers for Biomedical Applications: Improvement of the Interface Compatibility

Multiple functionalities of polyelectrolyte multilayer films: new biomedical applications.

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Interaction of Structured and Functionalized Polymers with Cancer Cells

Functional polymer thin films designed for antifouling materials and biosensors

In Vitro Cell Interactions on PVDF Films: Effects of Surface Morphology and Polar Phase Transition

Polymer Thin Films and Surface Modification by Chemical Vapor Deposition: Recent Progress.

Acetic-Acid Plasma-Polymerization on Polymeric Substrates for Biomedical Application

Future antiviral polymers by plasma processing

Novel transparent poly(silazane) derived solvent-resistant, bio-compatible microchannels and substrates: application in microsystem technology

A DR/NIR Hybrid Polymeric Tool for Functional Bio-Coatings: Theoretical Study, Cytotoxicity, and Antimicrobial Activity

Biomimetic Smart Interface Materials for Biological Applications

Applications of soft biomaterials based on organic and hybrid thin films deposited from the vapor phase

Star-polymers as potent broad-spectrum extracellular virucidal antivirals

Advanced functional polymer materials for biomedical applications

Biomedical polymers: synthesis, properties, and applications

Reversible rearrangement of the cellular cytoskeleton: A key to the broad-spectrum antiviral activity of novel amphiphilic polymers

Fungal Attachment-Resistant Polymers for the Additive Manufacture of Medical Devices

Photocurable bioresorbable adhesives as functional interfaces between flexible bioelectronic devices and soft biological tissues

New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets